Catherine Skari
-
Nov- 2020 -16 NovemberNews
Cyprus President Anastasiades Welcomed A TIF Delegation
An official meeting with the President of the Republic of Cyprus, Mr. Nicos Anastasiades, was held this morning by a…
Read More » -
12 November
-
12 November
-
Oct- 2020 -26 OctoberNews
Roche and Atea Pharmaceuticals Link Up To Co-Develop Remdesivir Rival Drug For COVID-19
The two companies will jointly develop, manufacture and distribute AT-527, Atea’s investigational oral antiviral for the potential treatment of COVID-19.…
Read More » -
Nov- 2020 -10 NovemberTIF News
Leave No Patient Behind: A TIF Declaration For Access To Health At The Time of The COVID-19 Pandemic
Download the TIF Declaration HERE
Read More » -
9 November
-
6 NovemberNews
What’s New In Clinical Trials for Thalassaemia and Sickle Cell Disease?
There is a lot of hustle and bustle in the scientific fields of thalassemia and sickle cell disease during the…
Read More » -
Oct- 2020 -25 October
-
24 OctoberNews
TIF Participates in EMA’s Annual Training Day 2020
TIF has participated in the Annual Training Day of the European Medicines Agency (EMA), held on 23 October 2020. TIF…
Read More » -
Nov- 2020 -5 NovemberNews
EU Approves Adakveo to Treat Vaso Occlusive Crises in Sickle Cell Disease Patients
The European Commission has approved Novartis’ Adakveo (crizanlizumab) as a preventive treatment for recurrent Vaso-Occlusive Crises (VOCs) in patients, 16 and older, with sickle cell…
Read More »
